Assessing the impact of elexacaftor/tezacaftor/ivacaftor on work productivity and activity impairment in people living with cystic fibrosis in Canada.
- DOI
- 10.1016/j.jcf.2026.09.005
- Published
- 2026 Sep 14
- Container
- Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.jcf.2026.09.005,
title = {Assessing the impact of elexacaftor/tezacaftor/ivacaftor on work productivity and activity impairment in people living with cystic fibrosis in Canada.},
author = {Kim GG and Wong T and Rayment J and Bilodeau L and Tullis E and Lands LC and Leung WM and Lam GY and Ratjen F and Quon BS and Can-IMPACT-CF Study Group},
year = {2026},
journal = {Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society},
doi = {10.1016/j.jcf.2026.09.005},
url = {https://doi.org/10.1016/j.jcf.2026.09.005}
}RIS
TY - JOUR TI - Assessing the impact of elexacaftor/tezacaftor/ivacaftor on work productivity and activity impairment in people living with cystic fibrosis in Canada. AU - Kim GG AU - Wong T AU - Rayment J AU - Bilodeau L AU - Tullis E AU - Lands LC AU - Leung WM AU - Lam GY AU - Ratjen F AU - Quon BS AU - Can-IMPACT-CF Study Group PY - 2026 JO - Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society DO - 10.1016/j.jcf.2026.09.005 UR - https://doi.org/10.1016/j.jcf.2026.09.005 ER -
APA
GG, K., T, W., J, R., L, B., E, T., LC, L., WM, L., GY, L., F, R., BS, Q., & Group, C. S. (2026). Assessing the impact of elexacaftor/tezacaftor/ivacaftor on work productivity and activity impairment in people living with cystic fibrosis in Canada.. Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society. https://doi.org/10.1016/j.jcf.2026.09.005
Source records
- pubmed · retrieved 2026-09-26T13:46:33.582Z